Social Media & Podcast Awards Judging Committee

Chair:

Harshit Jain, MD, Founder & Global CEO 
Doceree, New Jersey, United States

Dr. Harshit Jain is the Founder and Global CEO of Doceree, the world’s leading healthcare marketing platform building programmatic solutions for HCPs marketing. Founding Doceree in 2020, Harshit is aiming to address the acute problem of rising costs of healthcare by bringing in efficiency and effectiveness in marketing to Physicians by pharma brands on digital platforms with methodical use of data and creativity.

A Northwestern University graduate, Dr. Jain practiced as a physician for eight years before transitioning into advertising, holding leadership roles as Country Head and Engagement Lead at McCann Worldgroup for India, Europe and the United States. By leveraging the medical expertise of a ‘former physician’ and creative acumen of a ‘global marketer’, Dr. Jain crafted some of the industry’s most impactful global healthcare campaigns, earning him some of the biggest industry accolades, including Lions Grand Prix for Good; D&AD awards, India’s first Black Pencil, and many more. 

In 2020, Harshit Jain, MD, commenced his journey as the global entrepreneur with the launch of Doceree, the world’s first network of HCP-only platforms for programmatic advertising. From a mere 3 members to an expansion of over 90 percent in just 3.5 years of operations, Dr. Jain raised over $50M and expanded the company’s operations to 25 countries across 5 continents by introducing 8+ pioneering products to advance technology-powered innovations in the pharmaceutical marketing industry for 650+ pharmaceutical clients, including the world’s top 8 pharmaceutical brands. For his work at Doceree, Dr. Jain received Elite Disruptor by PM360 Magazine (2020); Pinnacle Award and 40 under 40 by MM+M (2021); Tech 25 Trailblazers by Entrepreneur Magazine (2023); Globee Gold Technology Thought Leader (2024); Titan Gold Entrepreneur For Health Product/Services (2024), Viddy's Gold Healthcare Marketing Podcaster (2024) and many more. 

Committee: